Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06234384 · ClinicalTrials.gov registry record

Foundation for Sarcoidosis Research Advanced Cures Registry (FSR-SARC Registry)

A clinical trial of Sarcoidosis, sponsored by Foundation for Sarcoidosis Research.

Recruiting
Registry status
6,833
Enrollment target
1
Study location

NCT06234384 is a study of Sarcoidosis that is actively recruiting participants, run by Foundation for Sarcoidosis Research. The registered enrollment target is 6,833 participants, above the 1,844-participant average among 21 other Sarcoidosis trials with a reported enrollment target (271% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06234384, a study of Sarcoidosis, is actively recruiting participants, sponsored by Foundation for Sarcoidosis Research.

RECRUITING
Registry status
6,833 participants
Enrollment target
1
Study location

Study Summary

The goal of the study is to create a longitudinal record of patient reported outcomes for people living with sarcoidosis that maintains privacy. Patients report on the following: demographics, disease symptoms, diagnostic journey, provider experience, disease treatment, and burden of disease. Patients can also link their Electronic Health Records (EHR). The goal is to create a natural history of sarcoidosis, support research, and better understand the needs of the sarcoidosis community.

Conditions Studied

Interventions

  • OTHER Sarcoidosis diagnosis

Study Locations (1)

Illinois

  • Foundation For Sarcoidosis Research - Chicago

Trial Details

FieldValue
Enrollment Target 6,833 participants
Start Date 2013-07
Est. Completion 2033-07

What the Registry Record Tells You About NCT06234384

The ClinicalTrials.gov registry entry for NCT06234384 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 6,833 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,844-participant average among 21 other Sarcoidosis trials with a reported enrollment target (271% higher). The listed sponsor is Foundation for Sarcoidosis Research, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sarcoidosis appearing as the primary indexed condition, and to 1 intervention - of which Sarcoidosis diagnosis is the first listed.

NCT06234384 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06234384 about?

NCT06234384 is a clinical study titled "Foundation for Sarcoidosis Research Advanced Cures Registry (FSR-SARC Registry)". The goal of the study is to create a longitudinal record of patient reported outcomes for people living with sarcoidosis that maintains privacy. Patients report on the following: demographics, disease symptoms, diagnostic journey, provider experience, disease treatment, and burden of disease. Patien...

What is the current status of trial NCT06234384?

This trial is currently recruiting. The enrollment target is 6,833 participants. The study started on 2013-07. Estimated completion is 2033-07.

What conditions does trial NCT06234384 study?

This clinical trial studies the following conditions: Sarcoidosis.

What interventions are being tested in trial NCT06234384?

The interventions under investigation include: Sarcoidosis diagnosis (OTHER).

Who is sponsoring clinical trial NCT06234384?

This trial is sponsored by Foundation for Sarcoidosis Research, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06234384 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sarcoidosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.